.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Queensland Health
Cerilliant
Deloitte
Healthtrust
Julphar
Fish and Richardson
Colorcon
Express Scripts
McKesson

Generated: June 28, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019841

« Back to Dashboard
NDA 019841 describes INDIUM IN 111 CHLORIDE, which is a drug marketed by Mallinkrodt Nuclear and is included in one NDA. It is available from two suppliers. Additional details are available on the INDIUM IN 111 CHLORIDE profile page.

The generic ingredient in INDIUM IN 111 CHLORIDE is indium in-111 chloride. There are twenty-three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the indium in-111 chloride profile page.

Summary for NDA: 019841

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 019841

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
INDIUM IN 111 CHLORIDE
indium in-111 chloride
INJECTABLE;INJECTION 019841 NDA Mallinckrodt Inc. 0019-9132 0019-9132-06 1 VIAL, GLASS in 1 CAN (0019-9132-06) > .5 mL in 1 VIAL, GLASS
INDIUM IN 111 CHLORIDE
indium in-111 chloride
INJECTABLE;INJECTION 019841 NDA MALLINCKRODT NUCLEAR MEDICINE LLC 69945-132 69945-132-06 1 VIAL, GLASS in 1 CAN (69945-132-06) > .5 mL in 1 VIAL, GLASS

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength5mCi/0.5ML
Approval Date:Sep 27, 1994TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Federal Trade Commission
Colorcon
Dow
UBS
Harvard Business School
Cantor Fitzgerald
McKinsey
McKesson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot